Markets:

Overview

News

Currencies

International

Treasuries

Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

4.455 -0.385 (-7.95%)

Streaming Delayed Price Updated: 10:25 AM EDT, Mar 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Iovance Biotherapeutics, Inc. - Common Stock

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

22 23 Next >

10 Health Care Stocks Whale Activity In Today's Session ↗

December 27, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 27, 2023

Via Benzinga

Gold Gains 1%; Richmond Fed Manufacturing Index Falls In December ↗

December 27, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 80 points on Wednesday. The Dow traded up 0.22% to 37,626.76 while the NASDAQ rose 0.06% to 15,084.02. The S&P...

Via Benzinga

Topics Economy Stocks

Iovance Biotherapeutics, Nio, NetEase And Other Big Stocks Moving Lower On Wednesday ↗

December 27, 2023

U.S. stocks traded mostly higher, with the Dow Jones index gaining around 80 points on Wednesday.

Via Benzinga

Topics Stocks

Why Iovance Biotherapeutics Stock Is Crashing Today ↗

December 27, 2023

One of the small biotech's top pipeline programs ran into a major setback.

Via The Motley Fool

Why Iovance Biotherapeutics Stock Is Jumping Today ↗

November 20, 2023

Another Wall Street analyst has jumped aboard the Iovance train.

Via The Motley Fool

Why Iovance Biotherapeutics Stock Is Marching Higher Today ↗

November 08, 2023

Investors are excited by the prospects of a potential regulatory approval.

Via The Motley Fool

FDA Slaps Clinical Hold On Iovance Biotherapeutics' Lung Cancer Study After Patient Death ↗

December 27, 2023

Wednesday, Iovance Biotherapeutics Inc (NASDAQ: IOVA) announced a clinical program update for LN-145 TIL therapy in non-

Via Benzinga

US Stocks Edge Higher; Coherus Reports FDA Approval Of UDENYCA ONBODY ↗

December 27, 2023

U.S. stocks traded slightly higher this morning, with the Dow Jones index gaining more than 20 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.08% to 37,575.13 while...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 27, 2023

Via Benzinga

Iovance Biotherapeutics Announces Clinical Program Update for LN-145 in Non-Small Cell Lung Cancer

December 27, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Analyst Expectations for Iovance Biotherapeutics's Future ↗

November 08, 2023

Via Benzinga

Earnings Preview: Iovance Biotherapeutics ↗

November 06, 2023

Via Benzinga

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

December 22, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Better Growth Stock: Viking Therapeutics or Iovance Biotherapeutics? ↗

December 12, 2023

Both of these pharma stocks could be big winners. But one stock screens as a better buy from a risk standpoint.

Via The Motley Fool

A Bull Market Is Coming: 1 Stock That Could Rocket 219% Higher in 2024, According to Wall Street ↗

December 12, 2023

There's a huge gap between what the stock market and Wall Street analysts have to say about this often-overlooked growth stock.

Via The Motley Fool

Crude Oil Gains Over 2%; PaxMedica Shares Plunge ↗

November 20, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining over 100 points on Monday. The Dow traded up 0.34% to 35,064.42 while the NASDAQ rose 0.80% to 14,238.67. The S&P 500...

Via Benzinga

Topics Stocks

Why ReNew Energy Global Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

November 20, 2023

Shares of ReNew Energy Global Plc (NASDAQ: RNW) gained during Monday’s session following strong quarterly sales. ReNew Energy Global posted quarterly sales of $345.00 million, topping market estimates...

Via Benzinga

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

November 17, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

5 OTC Stocks With The Potential To Explode In 2024 ↗

November 08, 2023

Investors who are ready to dive into the OTC pool have more options than ever, both with the number of stocks to choose from and available investing platforms.

Via Benzinga

Iovance Biotherapeutics Reports Third Quarter and Year-to-Date 2023 Financial Results and Corporate Updates

November 07, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2023 Financial Results Conference Call and Webcast on Tuesday, November 7, 2023

October 31, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Iovance Biotherapeutics to Present Clinical and Pre-Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapies at Society for Tumor Immunotherapy of Cancer’s (SITC) 38th Annual Meeting

October 31, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

October 20, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Tesla, Nokia And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

October 19, 2023

U.S. stock futures traded lower this morning on Thursday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Iovance Biotherapeutics Announces Clinical Data for Lifileucel in Advanced Mucosal Melanoma at the European Society for Medical Oncology (ESMO) Congress

October 16, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race

October 10, 2023

Large pharmaceutical companies are increasingly investing in cancer treatment stocks, driven by the promise of medical breakthroughs and financial rewards. Eli Lilly became the latest Big Pharma giant...

Via PressReach

Iovance Biotherapeutics to Present Clinical and Pre-Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapies at Society for Tumor Immunotherapy of Cancer’s (SITC) 38th Annual Meeting

September 27, 2023

Four-year Analysis of C-144-01 Trial Cohorts 2 and 4

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

September 22, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

10 Health Care Stocks Whale Activity In Today's Session ↗

September 18, 2023

Via Benzinga

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Delivering useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments.

Newsletters

The top stories, industry insights and relevant research, assembled by our editors and delivered to your inbox.

Connect

http://www.facebook.com/pages/Cabling-Installation-and-Maintenance/298118662118

https://www.instagram.com/cim_magazine/

https://www.linkedin.com/company/3962332

http://twitter.com/CABLINGMAG

Affiliated Brands

DATA CENTER FRONTIER

ISE

LIGHTWAVE

DIGITAL INFRASTRUCTURE GROUP

About Us
Advertise
Do Not Sell or Share
Privacy Policy
Terms & Conditions